{
    "clinical_study": {
        "@rank": "119473", 
        "arm_group": {
            "arm_group_label": "Breast Cancer ACR BI-RAD Category 3 or 4 result"
        }, 
        "biospec_descr": {
            "textblock": "35mL or 2 1/2 tablespoons of blood will be drawn from your arm"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The major purpose of this study is to evaluate a laboratory developed test that measures\n      multiple breast cancer-specific biomarker proteins and multiple antibodies in your blood\n      samples. The biomarker and antibody results along with your personal medical profile will be\n      evaluated to determine your risk for the presence of a malignancy in the breast as compared\n      to your breast evaluation assessment conducted by your physician."
        }, 
        "brief_title": "Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol", 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult women from 25 years of age to below 75 years of age\n\n          -  Breast evaluation results of ACR BI-RADS\u00ae Category 3 or 4 by imaging and physicians\n             clinical and radiological evaluation\n\n          -  Study visit and blood collection within 4 weeks (28 days)  of ACR BI-RADS assessment\n\n          -  Patient agrees to with additional health data being gathered at 6 months post\n             assessment for diagnostic follow-up\n\n          -  Samples collected under IRB approval and Informed Consent\n\n          -  Testing performed under IRB approval or waiver (as applicable)\n\n          -  Previous approved procedures to enroll patients: breast augmentation & cyst\n             aspiration\n\n        Exclusion Criteria:\n\n          -  Adults from 76 years of age or older and below 25 years of age\n\n          -  Final breast evaluation results other than a ACR BI-RADS Category 3 or 4\n\n          -  Subjects that have had a breast biopsy performed during the 6 months prior to the\n             study visit\n\n          -  Samples not collected under IRB approval and Informed Consent\n\n          -  Testing not performed under IRB approval or waiver (as applicable)\n\n          -  Prior breast cancer diagnosis."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "25 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary Care Clinics"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02078570", 
            "org_study_id": "dtectDx-Breast-002"
        }, 
        "lastchanged_date": "May 14, 2014", 
        "link": {
            "description": "Related Info", 
            "url": "http://www.provistadx.com"
        }, 
        "location": [
            {
                "contact": {
                    "email": "Valencerina.MariaAnna@scrippshealth.org", 
                    "last_name": "Anna Valencerina", 
                    "phone": "858-652-5538"
                }, 
                "contact_backup": {
                    "email": "Perez.Alain@scrippshealth.org", 
                    "last_name": "Alain Perez", 
                    "phone": "858-554-9379"
                }, 
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "Scripps"
                }, 
                "investigator": {
                    "last_name": "Carrie Constantini, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Tpearce1@hfh.edu", 
                    "last_name": "Tiffany Pearce", 
                    "phone": "313-916-1784"
                }, 
                "contact_backup": {
                    "email": "Skurian2@hfhs.org", 
                    "last_name": "Sheba Kurian", 
                    "phone": "313-916-7277"
                }, 
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Henry Ford Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Haythem Ali, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Biren Shah, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Heidi.Demouth@avera.org", 
                    "last_name": "Heidi Demouth", 
                    "phone": "605-322-3295"
                }, 
                "contact_backup": {
                    "email": "Daniel.Norfolk@avera.org", 
                    "last_name": "Daniel Norfolk", 
                    "phone": "605-322-3291"
                }, 
                "facility": {
                    "address": {
                        "city": "Sioux Falls", 
                        "country": "United States", 
                        "state": "South Dakota", 
                        "zip": "57105"
                    }, 
                    "name": "Avera Research Institute"
                }, 
                "investigator": [
                    {
                        "last_name": "Josie Alpers, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Amy Krie, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "bormans@provistadx.com", 
            "last_name": "Sherri Borman", 
            "phone": "480-344-9210"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Part I: Establish an acceptable algorithm for the generation of a single numerical score from the combination of the 10 cancer biomarkers that comprise the dtectDx Breast v2.0 Assay Part II: Define a numerical score cutoff that differentiates malignant from nonmalignant breast cancer in this population of woman", 
                "measure": "Quantitative Protein Algorithmic Score (QPAS)", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Demonstrate proof-of-concept for use of the dtectDx-Breast Assay to assess likelihood of breast cancer malignancy in conjunction with the physicians clinical and radiological evaluations.", 
                "measure": "Modified Quantitative Protein Algorithmic Score (QPAS)", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02078570"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Demonstrate the numerical score, collaborated via proprietary algorithm , for the dtectDx-Breast Assay v2.0 increases the likelihood of malignant breast cancer detection when used adjunctively with the assessment of BI-RADS Categories 3 and 4 compared to the assessment of BI-RADS Categories 3 and 4 alone.", 
            "measure": "QPAS relative to BI-RADS", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "source": "Provista Diagnostics, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Provista Diagnostics, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}